Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000
Reexamination Certificate
active
11135217
ABSTRACT:
A process is provided for preparing the dipeptidyl peptidase of the structure I(also referred to as saxaglipitin)by direct dehydration, in one pot, of the amide IIby reacting amide II with phosphorus oxychloride in an organic solvent such as dichloromethane, quenching the reaction mixture with water to form the hydrochloric acid salt of I, and treating the hydrochloric acid salt with base to form the free base of I.
REFERENCES:
patent: 6068991 (2000-05-01), Liu et al.
patent: 6395767 (2002-05-01), Robl et al.
patent: 2005/0090539 (2005-04-01), Vu et al.
patent: 0 808 824 (1997-11-01), None
patent: WO 00/04179 (2000-01-01), None
U.S. Appl. No. 11/091,183, filed Mar. 28, 2005, Sharma et al.
U.S. Appl. No. 11/104,015, filed Apr. 12, 2005, Politino et al.
U.S. Appl. No. 11/119,552, filed May 2, 2005, Patel et al.
Hanessian, S. et al., “Probing the Importance of Spacial and Conformational Domains in Captopril Analogs for Angiotensin Converting Enzyme Activity”, Bioorganic & Medicinal Chemistry Letters, vol. 8, pp. 2123-2128 (1998).
Hanson, R.L. et al., Synthesis of allysine ethylene acetal using phenylalanine dehydrogenase fromThermoactinomyces intermedius, Enzyme and Microbial Technology, vol. 26, pp. 348-358 (2000).
Imashiro, R. et al., “Asymmetric synthesis of methyl (2R,3S)-3-(4-methoxyphenyl) glycidate, a key intermediate of diltiazem, via Mukaiyama aldol reaction”, Tetrahedron Letters, vol. 42, pp. 1313-1315 (2001).
Reetz, M.T. et al., “General Synthesis of Potentially Antiviral α-Adamantyl Carbonyl Compounds”, Angew. Chem. Int. Ed. Engl., vol. 18, No. 1, p. 72 (1979).
Reetz, M.T. et al., “Lewis-Säure-bedingte α-tert-Alkylierung von Carbonsäuren und Carbonsäureestern”, Chem. Ber., vol. 116, pp. 3708-3724 (1983).
Reetz, M.T. et al., “Regioselektive Lewis-Säure-bedingte α-tert-Alkylierung von Acyloinen und Glycolsäure”, Chem. Ber., vol. 116, pp. 3702-3707 (1983).
Sagnard, I. et al., “Enantioselective Synthesis of Cyclopropane α-Amino Acids: Synthesis of N-Boc-cis-(2S,3R,4S)-3,4-Methanoproline and N-Boc-(2S,3R,4S)-3,4-Methanoglutamic Acid”, Tetrahedron Letters, vol. 36, No. 18, pp. 3148-3152 (1995).
Takada, H. et al., “Thermostable Phenylalanine Dehydrogenase ofThermoactinomyces intermedius: Cloning, Expression, and Sequencing of Its Gene”, J. Biochem., vol. 109, pp. 371-376 (1991).
Tverezovsky, V.V. et al., “Synthesis of (2S, 3R, 4S)-3,4-Methanoproline and Analogues by Cyclopropylidene Insertion”, Tetrahedron, vol. 53, No. 43, pp. 14773-14792 (1997).
Bristol--Myers Squibb Company
Rodney Burton
LandOfFree
Process for producing a dipeptidyl peptidase IV inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing a dipeptidyl peptidase IV inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing a dipeptidyl peptidase IV inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3806551